Axon Enterprise just released its Q3 2026 report and the market slammed the brakes. The stock closed down 18.2% to about US$313, even though revenue was roughly US$909 million and adjusted EBITDA margin was near 26% for the quarter.
Traders treated the session like an air pocket in a drone flight, reacting to a sharp reset in free cash flow and guidance as if the earnings power had vanished. The core issue is a tension between short term cash strain and a software heavy public safety platform that is still scaling.
Love Axon Enterprise's revenue scale and margins but worried about the impact on free cash flow and the guidance reset? Compare that profile with our list of solid balance sheet and fundamentals stocks (24 results)
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs. Q3 2025):US$908.6m vs. US$710.6m (up about 28%)
-
Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025):US$57.0m vs. a loss of US$2.2m (returned to profit)
-
Basic EPS (Q3 2026 vs. Q3 2025):US$0.70 vs. a loss of US$0.03 per share (moved back into positive earnings per share)
-
Adjusted EBITDA Margin (Q3 2026 vs. Q3 2025):25.9% in Q3 2026 vs. prior year not disclosed (supports Axon Enterprise's cash generation profile despite inventory build)
Earnings tell one story for Axon Enterprise, but investors who care about what the business can return over time usually focus on the cash coming in and out of the company. When you line up Axon Enterprise's cash flows against the current share price, the stock could be a clear 26% undervalued .
Axon bullish thesis: ARR engine gets real‑world test
The upbeat story says Axon Enterprise can turn AI era products and global demand into richer software contracts and a sturdier recurring base.
"The ongoing shift by public safety agencies from basic contracts to premium plans and AI enabled bundles is visible in Axon Enterprise's 39% annual recurring revenue growth to US$1.6b, net revenue retention of 126%, and future contracted bookings of US$15.1b."
Q3 backs up that direction. Software & Services reached US$437m and is nearing half of overall revenue. ARR is now US$1.8b with NRR still 126%. Record Q3 sales and more than 20% growth in 5 year normalized bookings indicate the premium bundle push is holding even as free cash flow runs tighter.
Axon bearish thesis: hardware, budgets and cash constraints
The worry is that hardware mix, government dependence, and funding choices could blunt that recurring revenue engine.
"Newer offerings such as counter drone hardware and related services, along with rising memory costs for cameras, are currently a drag on connected devices margins and are expected to weigh on adjusted EBITDA in the near term."
Q3 margins show that pressure in action. Adjusted gross margin sits at 59.2% while memory inflation is already a headwind, with a larger hit flagged for Q4 and into 2027 to 2028. Platform Solutions revenue of US$125m and inventory built by about US$100m support future deployments yet squeeze 2026 free cash flow, now guided to US$350m to US$400m.
One Narrative disagrees with today's price. → See where this Narrative says Axon Enterprise should trade .
Hunt For Mispriced Cash Engines
Axon Enterprise just showed how fast sentiment can swing when near term cash and long term plans collide. The real opportunity is spotting stocks that could be undervalued before the crowd catches on.
-
Company 1 - 42% below our estimate - uses advanced cash recycling machines and branch-in-a-box installations to replace legacy teller setups for banks.
-
Company 2 - 15% below our estimate - shifts its chip portfolio toward silicon carbide and GaN components that power electric vehicles and AI data centers.
-
Company 3 - 36% below our estimate - anchors digital infrastructure with custom silicon and software that route, secure and manage traffic for large scale data workloads.
Three companies from the same screener. Open every one of the 39 undervalued companies on it →
This article is general in nature and was produced with the assistance of AI automation, based on data and analysis from Simply Wall St. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AXON .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
